Journal of Hematology & Oncology

official impact factor 2.93

Open Access Short report

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Matthias Schwenkglenks*, Ruth Pettengell, Thomas D Szucs, Eva Culakova and Gary H Lyman

Journal of Hematology & Oncology 2010, 3:27 doi:10.1186/1756-8722-3-27

No comments have yet been made on this article.

Post a comment